S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
TSE:NBLY

Neighbourly Pharmacy (NBLY) Stock Forecast, Price & News

C$12.56
-0.22 (-1.72%)
(As of 09/29/2023 ET)
Compare
Today's Range
C$12.50
C$12.85
50-Day Range
C$12.78
C$18.24
52-Week Range
C$12.50
C$25.50
Volume
33,965 shs
Average Volume
39,178 shs
Market Capitalization
C$561.06 million
P/E Ratio
N/A
Dividend Yield
1.43%
Price Target
C$24.50

Neighbourly Pharmacy MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
95.1% Upside
C$24.50 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.06 out of 5 stars


NBLY stock logo

About Neighbourly Pharmacy (TSE:NBLY) Stock

Neighbourly Pharmacy Inc. owns and operates a chain of retail pharmacies in Canada. The company sells prescription medication, confections and food, over the counter drugs, and health and beauty aids. It operates pharmacies under the various banners, such as IDA/Guardian, Pharmachoice, Pharmasave, Remedy's RX, and Drug Trading. The company was incorporated in 2015 and is headquartered in Toronto, Canada.

NBLY Price History

NBLY Stock News Headlines

Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
2 Stocks That Could Beat a Bear Market
Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
Neighbourly Announces Annual Meeting Results
Neighbourly Announces Strong First Quarter Results
NBLY.TO - Neighbourly Pharmacy Inc.
RBC Capital Remains a Buy on Neighbourly Pharmacy, Inc. (NBLY)
1 TSX Bargain Stock I’m Adding to My Basket
See More Headlines
Receive NBLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neighbourly Pharmacy and its competitors with MarketBeat's FREE daily newsletter.

NBLY Company Calendar

Ex-Dividend for 8/3 Dividend
7/05/2023
Dividend Payable
8/03/2023
Ex-Dividend for 9/26 Dividend
8/28/2023
Dividend Payable
9/26/2023
Today
9/29/2023

Industry, Sector and Symbol

Industry
Pharmaceutical Retailers
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
3,648
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
C$24.50
High Stock Price Forecast
C$30.00
Low Stock Price Forecast
C$20.00
Forecasted Upside/Downside
+91.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
6 Analysts

Profitability

Net Income
C$-26,610,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$831.61 million
Cash Flow
C$0.41 per share
Book Value
C$13.42 per share

Miscellaneous

Free Float
N/A
Market Cap
C$570.88 million
Optionable
Not Optionable
Beta
0.57
The Best High-Yield Dividend Stocks for 2023 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Skip Bourdo (Age 46)
    CEO & Director
    Comp: $604.17k
  • Mr. Billy Wong C.M.A.
    CPA, M.B.A., Chief Financial Officer
  • Mr. Jari Pekka Villanen (Age 52)
    Sr. VP of Operations
    Comp: $307.48k
  • Mr. Roy J. Wieschkowski (Age 60)
    Sr. VP of People & Culture
    Comp: $255.84k
  • Mr. Steve Losty (Age 49)
    Chief Devel. Officer
    Comp: $302.15k













NBLY Stock - Frequently Asked Questions

Should I buy or sell Neighbourly Pharmacy stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Neighbourly Pharmacy in the last twelve months. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" NBLY shares.
View NBLY analyst ratings
or view top-rated stocks.

What is Neighbourly Pharmacy's stock price forecast for 2023?

6 brokerages have issued twelve-month target prices for Neighbourly Pharmacy's shares. Their NBLY share price forecasts range from C$20.00 to C$30.00. On average, they predict the company's stock price to reach C$24.50 in the next year. This suggests a possible upside of 91.7% from the stock's current price.
View analysts price targets for NBLY
or view top-rated stocks among Wall Street analysts.

How have NBLY shares performed in 2023?

Neighbourly Pharmacy's stock was trading at C$23.39 at the start of the year. Since then, NBLY shares have decreased by 45.4% and is now trading at C$12.78.
View the best growth stocks for 2023 here
.

How often does Neighbourly Pharmacy pay dividends? What is the dividend yield for Neighbourly Pharmacy?

Neighbourly Pharmacy announced a quarterly dividend on Monday, August 28th. Shareholders of record on Tuesday, September 26th will be given a dividend of 0.045 per share on Tuesday, September 26th. This represents a $0.18 annualized dividend and a dividend yield of 1.41%. The ex-dividend date of this dividend is Monday, August 28th.
Read our dividend analysis for NBLY
.

Is Neighbourly Pharmacy a good dividend stock?

Neighbourly Pharmacy (TSE:NBLY) pays an annual dividend of C$0.18 per share and currently has a dividend yield of 1.28%.
Read our dividend analysis for NBLY.

What is Neighbourly Pharmacy's stock symbol?

Neighbourly Pharmacy trades on the Toronto Stock Exchange (TSX) under the ticker symbol "NBLY."

How do I buy shares of Neighbourly Pharmacy?

Shares of NBLY stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Neighbourly Pharmacy's stock price today?

One share of NBLY stock can currently be purchased for approximately C$12.78.

How much money does Neighbourly Pharmacy make?

Neighbourly Pharmacy (TSE:NBLY) has a market capitalization of C$570.88 million and generates C$831.61 million in revenue each year. The company earns C$-26,610,000.00 in net income (profit) each year or C($0.61) on an earnings per share basis.

How many employees does Neighbourly Pharmacy have?

The company employs 3,648 workers across the globe.

How can I contact Neighbourly Pharmacy?

Neighbourly Pharmacy's mailing address is 190 Attwell Drive, Unit 400, Toronto, ON M9W 6H8, Canada. The official website for the company is neighbourlypharmacy.ca. The company can be reached via phone at 416 309 9102.

This page (TSE:NBLY) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -